PIPELINE
With multiple products in development, Sutro is designing a better future across a range of medical conditions.
Sutro technology is driving the development of novel antibody-drug conjugates, vaccine therapy, immunotherapy, and groundbreaking immunostimulatory ADCs. Each element of the Sutro pipeline is ambitiously designed to address a specific unmet need.
SUTRO-LED PROGRAMS
PROGRAM
MODALITY
INDICATION
PHASE
PARTNER
![Luvelta pipeline.v5-Max-Quality](https://www.sutrobio.com/wp-content/uploads/2024/05/Luvelta-pipeline.v5-Max-Quality-scaled.jpg)
PROGRAM
MODALITY
INDICATION
PHASE
PARTNER
![STRO-004 pipeline.v1-Max-Quality](https://www.sutrobio.com/wp-content/uploads/2024/05/STRO-004-pipeline.v1-Max-Quality-scaled.jpg)
PROGRAM
MODALITY
INDICATION
PHASE
PARTNER
![Luvelta pipeline.v5-Max-Quality](https://www.sutrobio.com/wp-content/uploads/2024/05/Luvelta-pipeline.v5-Max-Quality-scaled.jpg)
![STRO-004 pipeline.v1-Max-Quality](https://www.sutrobio.com/wp-content/uploads/2024/05/STRO-004-pipeline.v1-Max-Quality-scaled.jpg)
PARTNER PROGRAMS
![Luvelta pipeline.v5-Max-Quality](https://www.sutrobio.com/wp-content/uploads/2024/05/Luvelta-pipeline.v5-Max-Quality-scaled.jpg)
![Luvelta pipeline.v5-Max-Quality](https://www.sutrobio.com/wp-content/uploads/2024/05/Luvelta-pipeline.v5-Max-Quality-scaled.jpg)
![Luvelta pipeline.v5-Max-Quality](https://www.sutrobio.com/wp-content/uploads/2024/05/Luvelta-pipeline.v5-Max-Quality-scaled.jpg)